KRAS G12C Peptide (TFA)
KRAS G12C Peptide TFA is the trifluoroacetate salt of KRAS G12C Peptide. KRAS G12C Peptide is a specific peptide derived from the Kirsten rat sarcoma virus (KRAS) gene carrying the G12C oncogenic mutation. KRAS G12C Peptide induces responses like IFN-γ secretion and cytotoxicity. KRAS G12C Peptide can be used for the study of immune responses against KRAS G12C-mutant tumors[1].
Product Specifications
UNSPSC
12352209
Target
IFNAR
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Purity
95.15
Smiles
O=C(N[C@@H](C(C)C)C(N[C@@H](C(C)C)C(NCC(N[C@@H](C)C(N[C@@H](CS)C(NCC(N[C@@H](C(C)C)C(NCC(N[C@@H](CCCCN)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](C(C)C)N.OC(C(F)(F)F)=O.[x]
Molecular Formula
C38H69N11O11S.xC2HF3O2
Molecular Weight
888.09 (free base)
References & Citations
[1]Zheng W, et al. Exploring the therapeutic potential of precision T-Cell Receptors (TCRs) in targeting KRAS G12D cancer through in vitro development. Oncol Res. 2024 Nov 13;32 (12) :1837-1850.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC401073-500 1x 500 µL
HLA-Aw32 & HLA-A25 (MHC I) (CATA-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941864-100 1x 100 µL
AMACR / p504S (Prostate Cancer Marker) (AMACR/1864), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details